Sodium Ferulate Reduces Portal Pressure Through Inhibition of RhoA/Rho-Kinase and Activation of Endothelial Nitric Oxide Synthase in Cirrhotic Rats

Digestive Diseases and Sciences
Jiqiao LiuQi Zhou

Abstract

Recent studies have demonstrated that increased RhoA/Rho-kinase activity and reduced nitric oxide activity have the necessary machinery to induce cirrhosis. However, it is unclear whether this regulates the functions of hepatic stellate cells (HSCs). In this study, we used sodium ferulate (SF) in a cirrhotic rat model and examined its roles in regulating RhoA activation in HSCs and the subsequent effects on contraction of HSCs. Bile duct ligation method was used to induce cirrhosis in rats. Intrahepatic resistance was investigated in in situ perfused livers. Hepatic RhoA, Rho-kinase and eNOS expressions were studied by RT-PCR and Western blot. RhoA pull-down assay and collagen gel contraction assay of HSCs were performed by incubation with SF in the absence or presence of GGPP. We showed that in cirrhotic liver, SF can efficiently affect RhoA activation via lowering the synthesis of GGPP in HSCs. These actions effectively reduced basal intrahepatic resistance in cirrhotic rats. Our study further suggested that SF effectively decreased Rho-kinase activity and increased activity of eNOS at both the mRNA and protein levels. SF treatment of HSCs reduced RhoA GTP without affecting the total RhoA protein level, and GGPP had the abili...Continue Reading

References

Jan 1, 1997·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·D Rockey
Sep 3, 1998·The Journal of Biological Chemistry·U Laufs, J K Liao
Dec 22, 1999·Biochemical and Biophysical Research Communications·N KawadaK Kaneda
Mar 23, 2000·Journal of Hepatology·J Bosch, J C García-Pagán
Jul 10, 2001·American Journal of Physiology. Cell Physiology·S SakuradaY Takuwa
Sep 22, 2001·Clinics in Liver Disease·V Shah
Dec 13, 2002·Nature·Sandrine Etienne-Manneville, Alan Hall
Jun 5, 2003·Nature Reviews. Molecular Cell Biology·Kirsi Riento, Anne J Ridley
Mar 11, 2005·Journal of Clinical Gastroenterology·Roberto J Groszmann, Juan G Abraldes
Nov 30, 2005·Journal of Hepatology·Mariapia VairettiRoberto Imberti
Dec 13, 2005·Circulation Research·Yoshiyuki Rikitake, James K Liao
May 1, 2007·Cardiovascular Research·David M Dudzinski, Thomas Michel
Jun 29, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jonel TrebickaJörg Heller
Jan 12, 2008·Journal of Clinical Biochemistry and Nutrition·Marimuthu SrinivasanVenugopal P Menon
May 20, 2008·The Anatomical Record : Advances in Integrative Anatomy and Evolutionary Biology·Hendrik ReynaertAlbert Geerts
Dec 26, 2008·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Mariapia VairettiUmberto Cillo
Mar 11, 2010·Journal of Clinical Biochemistry and Nutrition·Myoung Jin SonMi Young Kang
Mar 19, 2011·The Korean Journal of Hepatology·Moon Young KimSamuel S Lee
Nov 29, 2012·Journal of Cardiovascular Pharmacology·Md Ashraful AlamLindsay Brown
Jul 3, 2013·American Journal of Physiology. Gastrointestinal and Liver Physiology·Yedidya SaimanMeena B Bansal

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.